Oligohydramnios is a condition of pregnancy during which you have abnormally low levels of amniotic fluid, a substance that surrounds the fetus in the womb. Amniotic fluid is essential for your fetal growth, its protection, and overall well-being inside the uterus.
Oligohydramnios affects about 4% of pregnancies, with a higher chance in post-term pregnancies (≥42 weeks). The doctors calculate fluid level during ultrasound, using either the Amniotic Fluid Index (AFI) or the Single Deepest Pocket (SDP). If the AFI is less than 5 cm or the SDP is less than 2 cm, the pregnancy is categorized as oligohydramnios.
What Does Amniotic Fluid Do?
Amniotic fluid plays a very important role in maintaining a healthy pregnancy. Its key functions are:
- It provides a protective cushion that shields the fetus from external trauma or physical impact.
- The fluid helps maintain a stable environment, ensuring your baby stays at a constant temperature, which is crucial for development.
- The fluid enables the baby to move freely, which is important for the growth and development of the musculoskeletal system, including bones and muscles.
- It supports lung development by enabling the baby to “breathe” the fluid in and out, which is a rehearsal for post-birth breathing.
- The fluid continues into the gastrointestinal tract, which helps in maturation as a continuous process of intake and reabsorption.
- Amniotic fluid contains some immunologic components, but most fetal immunity comes from maternal IgG antibodies crossing the placenta, not from the fluid itself.
In normal pregnancy, the volume of the amniotic fluid gradually increases, reaching its highest levels around the 36th week; then, it decreases slightly as the gestation nears term.
Normal Levels of Amniotic Fluid During Pregnancy:
Amniotic fluid levels naturally change during the course of pregnancy. It reaches its highest levels during 34–36 weeks, i.e., about 800–1000 mL. After that, the volume slightly decreases as the pregnancy nears full term.
Doctors use ultrasound scans to measure fluid levels:
- Normal AFI: 8–18 cm
- Borderline: 5–8 cm
- Oligohydramnios: <5 cm
- Polyhydramnios (excess fluid): >24 cm
With the help of these levels, healthcare professionals make decisions on whether intervention is necessary.
Human fetus at 10 weeks with an amniotic sac. Image by lunar caustic, licensed under CC BY-SA 3.0 via Wikimedia Commons
Why Amniotic Fluid Levels Fluctuate:
Amniotic fluid levels are not constant—they fluctuate due to several reasons. For example:
- Maternal hydration directly affects the levels of fluid; on the other hand, dehydration can reduce the volume temporarily.
- Fetal urination also plays a major role since it contributes significantly to amniotic fluid. Any condition that affects fetal kidney function can lead to oligohydramnios.
- Another important factor is placental function. If the placenta cannot deliver enough nutrients and oxygen (for any reason), the fetus may produce less urine, resulting in reduced amniotic fluid levels.
Therefore, it is necessary to monitor these fluctuations to ensure a safe pregnancy outcome.
Causes & Risk Factors of Oligohydramnios
Oligohydramnios can occur when there is a decrease in amniotic fluid production, an inability to recycle the fluid, or leakage from the uterus. Common causes include:
Rupture of Membranes (PROM/PPROM):
Sometimes, the fluid leakage ruptures the amniotic sac. If this occurs before 37 weeks, it’s called preterm prelabor rupture of membranes (PPROM), which significantly increases the risk of oligohydramnios.
Placental Problems:
Some conditions greatly affect placental function, such as placental abruption, preeclampsia, or chronic hypertension. These can limit the flow of nutrients and oxygen to the fetus, decreasing fluid levels.
Twin-Twin Transfusion Syndrome (TTTS):
In monochorionic twin pregnancies, an imbalance of blood flow through connecting vessels in the shared placenta can occur. The “donor” twin experiences reduced blood volume, leading to poor kidney function and significantly reduced urine output, resulting in oligohydramnios.
Fetal Birth Defects:
Another reason is that abnormalities in the kidneys or urinary tract can decrease the urine output of the fetus, which is a primary source of amniotic fluid. For example, renal agenesis (absence of kidneys) or urinary tract obstruction.
Fetal water flow and amniotic fluid with an anatomical structure outline diagram.
Post-Term Pregnancy:
When a pregnancy lasts longer than 42 weeks, the placenta starts deteriorating in its function to produce amniotic fluid.
Maternal Health Conditions:
Oligohydramnios may be more likely to occur in women with chronic health problems such as uncontrolled diabetes, hypertension, dehydration, or autoimmune disorders such as lupus.
Maternal Smoking:
Smoking is a known risk factor, as nicotine can reduce blood flow to the placenta, impairing fetal renal function and leading to decreased urine production.
Drugs:
Some drugs, such as ACE inhibitors used to treat high blood pressure, have been linked to oligohydramnios, especially when used during the second or third trimester.
Signs & Symptoms of Oligohydramnios
Oligohydramnios may be a silent condition that does not always show up with any symptoms until an ultrasound is performed. Nevertheless, the possible symptoms are:
- Increase in watery discharge: Pregnant women could find a constant trickling or leaking of fluid in the vagina.
- Smaller-than-Expected Uterine Size: Because of less fluid in the uterus, its size can be smaller than expected for the age on examination.
- Less Fetal Movement: The mother experiences a significant slowing in the fetal movements.
If you feel a sudden leakage of fluid or a significant reduction in movements, you must go to the doctor immediately.
How is Oligohydramnios diagnosed?
Doctors can diagnose oligohydramnios only with the help of ultrasound, and there are two primary diagnostic modes:
- Amniotic Fluid Index (AFI): the uterus is divided into four quadrants, and the deepest fluid pocket in each of them is measured. An AFI of below 5 cm is an indication of oligohydramnios.
- Single Deepest Pocket (SDP): This is a measurement of the biggest vertical pocket of fluid. A measurement of less than 2 cm suggests oligohydramnios.
Once the diagnosis has been made, doctors also perform the following tests:
- Detailed Fetal Ultrasound: To check the kidneys, bladder, and urinary tract to see whether they are abnormal.
- Non-Stress Test (NST) or Biophysical Profile (BPP): To determine the baby’s well-being and movements.
- Doppler Flow Studies: To measure the blood circulation of the umbilical cord and fetal vessels.
- Mother’s Laboratory Tests: To determine conditions like preeclampsia or diabetes.
Potential Complications
You can determine oligohydramnios complications by the severity of the condition and at what stage in the pregnancy:
For the Baby:
- Pulmonary Hypoplasia: When oligohydramnios is present at a young stage, there is a high probability of the lungs remaining immaturely developed.
- Limb Deformities: The lack of movement may be succeeded by joint contractures or deformities.
- Umbilical Cord Compression: Cord compression can occur as a result of fluid absence and does not allow the delivery of oxygen and nutrients.
- Intrauterine Growth Restriction (IUGR): The inability of the placenta to function properly can be a cause of retarded fetal growth.
- Preterm Birth: A preterm birth may be necessary in case of fetal distress.
- Increased Risk of Miscarriage or Stillbirth: In severe cases, the possibility of miscarriage or stillbirth is high.
- Potter Sequence: In extreme cases of oligohydramnios, especially if the cause is fetal kidney agenesis, the baby may develop a combination of findings known as the Potter sequence. This includes:
For Mother:
- Labor Induction or C-Section: Doctors go for an emergency birth by inducing labor or a C-section in case the fetus is in distress.
- Psychological Stress: A high-risk pregnancy also causes emotional and mental stress.
Treatment & Management Strategies
There is no direct treatment to restore the fluid level, and therefore, we focus on monitoring and correcting the pathophysiology:
Maternal Hydration:
Doctors often recommend maternal hydration as an initial, non-invasive intervention. However, this is only helpful in mild cases. If the fluid level continues to decrease, some medical interventions may be required. Intravenous (IV) hydration can temporarily increase amniotic fluid levels.
Amnioinfusion:
Amnioinfusion is an intrapartum intervention, performed during labor, not a routine antenatal therapy. In this procedure, normal saline or Ringer’s lactate solution is injected into the amniotic sac through a catheter. It is used to relieve umbilical cord compression and improve fetal heart rate patterns.
Frequent Monitoring:
You can assess fetal health with the help of regular ultrasounds, NSTs, and BPPs. These tests assist the doctors in understanding the well-being of the fetus and in identifying any complications at an earlier stage.
Managing Underlying Conditions:
To achieve the best results, manage properly underlying conditions such as diabetes, high blood pressure, or dehydration.
Planned Delivery:
Delivery depends upon fluid levels, gestational age, and fetal health. Corticosteroid injections can be used in high-risk pregnancies in case the delivery is expected prematurely. The steroids assist in speeding up the process of lung development, which minimizes the chances of premature infants experiencing breathing complications.
Although these measures do not necessarily restore normal fluid reserves, they are important in enhancing the outcomes of pregnancy and minimizing the risks to a mother and her child.
Oligohydramnios vs. Polyhydramnios: A Clinical Comparison
| Feature | Oligohydramnios | Polyhydramnios |
|---|---|---|
| Definition | Too little amniotic fluid | Too much amniotic fluid |
| Diagnostic Criteria | AFI ≤ 5 cm or SDP < 2 cm | AFI ≥ 24 cm or SDP > 8 cm |
| Common Causes | Ruptured membranes, placental insufficiency, fetal kidney/urinary anomalies, maternal dehydration | Idiopathic (most common), maternal diabetes, fetal swallowing disorders, fetal anemia/infections, Twin-Twin Transfusion Syndrome |
| Maternal Symptoms | Reduced fetal movement, fluid leakage, and small uterine size | Large uterus, abdominal discomfort, preterm contractions, shortness of breath |
| Fetal/Neonatal Risks | Lung underdevelopment, limb deformities, cord compression, IUGR, Potter sequence (severe cases) | Preterm birth, macrosomia, malpresentation, maternal postpartum hemorrhage |
| Management | Hydration (oral/IV), close surveillance (NST, BPP, Doppler), amnioinfusion, timely delivery | Treat underlying cause, surveillance, amnioreduction (fluid removal), Indomethacin (with caution) |
| Clinical Exam | The uterus feels “all fetus,” parts are easily palpable | Uterus tense, large, globular; fetal parts hard to feel, muffled heart tones |
Oligohydramnios usually results from reduced fetal urine output, while Polyhydramnios is often due to impaired fetal swallowing or excess fluid production. Both require careful monitoring for safe outcomes.
Outlook & Prognosis
The outlook for a pregnancy affected by oligohydramnios largely depends on when it occurs, its severity, and the underlying causes. Mild cases detected late in pregnancy often have a favorable outcome with appropriate monitoring and timely delivery.
However, severe early-onset oligohydramnios can cause complications such as lung hypoplasia, intrauterine growth restriction, and preterm birth. For the best care, people with oligohydramnios must refer to a maternal-fetal medicine specialist for the most desirable result.
Can Oligohydramnios be prevented in future Pregnancies?
There is no one, universal rule for preventing oligohydramnios in the next pregnancy, as it depends on the cause in the previous pregnancy. To most women, it may not be preventable, but the risk can be reduced through proactive and collaborative care with a medical practitioner.
Here’s a breakdown based on potential causes:
- In case the cause is maternal health-related, the prevention is highly possible. When oligohydramnios is associated with chronic hypertension, preeclampsia, or diabetes, the best approach would be to control the underlying cause optimally during preconception and strictly control it during the subsequent pregnancy. This includes preconception counseling, collaboration with a specialist, and regular use of drugs and lifestyle plans.
- If the cause was a genetic or structural anomaly of the fetus, then prevention might not be possible when the anomaly is sporadic. You should discuss the recurrence risks with a gynaecologist and a genetic counselor; it may be very low in certain conditions and high in others. In other scenarios, a more advanced reproductive technology, or prenatal genetic testing in a subsequent pregnancy, could be considered.
- In case the cause was preterm prelabor rupture of membranes (PPROM), then this is usually unknown, and thus specific prevention is difficult. However, you should strictly control risk factors by quitting smoking, maintaining good nutrition, and treating any genital tract infections before another conception.
- In the absence of a specific cause, prevention is not aimed at. The focus is on increased surveillance during the subsequent pregnancy. This is possible with more early ultrasounds and more often to check the levels of fluids and to implement early intervention in case oligohydramnios recurs.
The consensus on any subsequent pregnancy after a previous oligohydramnios has been to follow preconception care. This will enable your doctor to examine your medical history, maximize your well-being, and develop a unique monitoring plan.
Conclusion
Oligohydramnios emphasizes the importance of amniotic fluid in the development of the fetus. Although the diagnosis is stressful, it is not a disease but a sign that should be carefully evaluated. You can determine the results by the time it occurs, its severity, and the cause.
Early cases are more dangerous, but the majority of cases that occur later on can be effectively risk-managed with close observation and prompt delivery. Obstetrics today has the benefit of modern ultrasound, frequent monitoring of the fetus, and a multidisciplinary team, and can provide effective methods of safeguarding the mother and the child.
The best plan for anticipating parents is to be well-informed, follow medical advice, attend every checkup, and be quick to report any changes of concern. Due to careful observation, a good number of pregnancies with oligohydramnios have been delivered normally.
References
[1] Phelan, J. P., Smith, C. V., Broussard, P., & Small, M. (1987). Amniotic fluid volume assessment with the four-quadrant technique at 36–42 weeks’ gestation.Journal of Reproductive Medicine, 32(7), 540–542.
[2] Magann, E. F., Chauhan, S. P., Doherty, D. A., Lutgendorf, M. A., Magann, M. I., & Morrison, J. C. (2007).A review of idiopathic oligohydramnios and pregnancy outcomes.Obstetrical & Gynecological Survey, 62(12), 795–802.
[3] Brace, R. A., & Wolf, E. J. (1989).Normal amniotic fluid volume changes throughout pregnancy.American Journal of Obstetrics and Gynecology, 161(2), 382–388.
[4] Chamberlain, P. F., Manning, F. A., Morrison, I., Harman, C. R., & Lange, I. R. (1984).Ultrasound evaluation of amniotic fluid volume: I. The relationship of marginal and decreased amniotic fluid volumes to perinatal outcome.American Journal of Obstetrics and Gynecology, 150(3), 245–249.
[5] Morris, R. K., Meller, C. H., Tamblyn, J., Malin, G. M., Riley, R. D., Kilby, M. D., & Khan, K. S. (2014).Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis.BJOG, 121(6), 686–699.
[6] Magann, E. F., Sandlin, A. T., & Ounpraseuth, S. T. (2011).Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios and polyhydramnios.Obstetrics and Gynecology Clinics of North America, 38(2), 387–400.
[7] Chauhan, S. P., Sanderson, M., Hendrix, N. W., Magann, E. F., & Devoe, L. D. (1999).Perinatal outcome and amniotic fluid index in the antepartum and intrapartum periods: a meta-analysis.American Journal of Obstetrics and Gynecology, 181(6), 1473–1478.
[8] Casey, B. M., McIntire, D. D., Bloom, S. L., Lucas, M. J., Santos, R., Twickler, D. M., & Leveno, K. J. (2000).Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation.American Journal of Obstetrics and Gynecology, 182(4), 909–912.
[9] Locatelli, A., Vergani, P., Toso, L., Verderio, M., Pezzullo, J. C., & Ghidini, A. (2003).Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies.Archives of Gynecology and Obstetrics, 269(2), 130–133.
[10] Morris, J. M., Thompson, K., Smithey, J., Gaffney, G., Cooke, I., Chamberlain, P., & Khan, K. S. (2003).The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study.BJOG, 110(11), 989–994.
[11] Casey, B. M., McIntire, D. D., Bloom, S. L., Lucas, M. J., Santos, R., Twickler, D. M., & Leveno, K. J. (2000).Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation.American Journal of Obstetrics and Gynecology, 182(4), 909–912.
[12] Magann, E. F., Chauhan, S. P., Doherty, D. A., Lutgendorf, M. A., Magann, M. I., & Morrison, J. C. (2007).A review of idiopathic oligohydramnios and pregnancy outcomes.Obstetrical & Gynecological Survey, 62(12), 795–802.
[13] Magann, E. F., Sandlin, A. T., & Ounpraseuth, S. T. (2011). Amniotic fluid and the clinical relevance of the sonographically estimated amniotic fluid volume: oligohydramnios and polyhydramnios. Obstetrics and Gynecology Clinics of North America, 38(2), 387–400.
[14] Morris, R. K., Meller, C. H., Tamblyn, J., Malin, G. M., Riley, R. D., Kilby, M. D., & Khan, K. S. (2014).Association and prediction of amniotic fluid measurements for adverse pregnancy outcome: systematic review and meta-analysis.BJOG, 121(6), 686–699.
[15] Casey, B. M., McIntire, D. D., Bloom, S. L., Lucas, M. J., Santos, R., Twickler, D. M., & Leveno, K. J. (2000).Pregnancy outcomes after antepartum diagnosis of oligohydramnios at or beyond 34 weeks’ gestation.American Journal of Obstetrics and Gynecology, 182(4), 909–912.
[16] Locatelli, A., Vergani, P., Toso, L., Verderio, M., Pezzullo, J. C., & Ghidini, A. (2003).Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies.Archives of Gynecology and Obstetrics, 269(2), 130–133.
[17] Magann, E. F., Chauhan, S. P., Doherty, D. A., Lutgendorf, M. A., Magann, M. I., & Morrison, J. C. (2007).A review of idiopathic oligohydramnios and pregnancy outcomes.Obstetrical & Gynecological Survey, 62(12), 795–802.
[18] Morris, J. M., Thompson, K., Smithey, J., Gaffney, G., Cooke, I., Chamberlain, P., & Khan, K. S. (2003).The usefulness of ultrasound assessment of amniotic fluid in predicting adverse outcome in prolonged pregnancy: a prospective blinded observational study.BJOG, 110(11), 989–994.